Cellectis SA (CLLS)
1.33
-0.05
(-3.62%)
USD |
NASDAQ |
Nov 12, 16:00
1.34
+0.01
(+0.75%)
After-Hours: 20:00
Cellectis Enterprise Value : 71.36M for Nov. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 71.36M |
| November 11, 2026 | 76.40M |
| November 10, 2026 | 49.21M |
| November 09, 2026 | 50.22M |
| November 06, 2026 | 45.18M |
| November 05, 2026 | 41.15M |
| November 04, 2026 | 55.25M |
| November 03, 2026 | 47.20M |
| November 02, 2026 | 41.66M |
| October 30, 2026 | 46.19M |
| October 29, 2026 | 55.25M |
| October 28, 2026 | 64.31M |
| October 27, 2026 | 43.17M |
| October 26, 2026 | 34.76M |
| October 23, 2026 | 36.12M |
| October 22, 2026 | 35.62M |
| October 21, 2026 | 34.96M |
| October 20, 2026 | 37.13M |
| October 19, 2026 | 30.63M |
| October 16, 2026 | 42.16M |
| October 15, 2026 | 48.71M |
| October 14, 2026 | 50.22M |
| October 13, 2026 | 48.20M |
| October 12, 2026 | 56.26M |
| October 09, 2026 | 64.31M |
| Date | Value |
|---|---|
| October 08, 2026 | 63.31M |
| October 07, 2026 | 72.37M |
| October 06, 2026 | 78.41M |
| October 05, 2026 | 79.42M |
| October 02, 2026 | 81.43M |
| October 01, 2026 | 78.41M |
| September 30, 2026 | 89.49M |
| September 29, 2026 | 85.46M |
| September 28, 2026 | 86.47M |
| September 25, 2026 | 85.46M |
| September 24, 2026 | 81.43M |
| September 23, 2026 | 82.44M |
| September 22, 2026 | 94.52M |
| September 21, 2026 | 89.49M |
| September 18, 2026 | 91.50M |
| September 17, 2026 | 84.45M |
| September 16, 2026 | 75.90M |
| September 15, 2026 | 99.56M |
| September 14, 2026 | 121.71M |
| September 11, 2026 | 249.60M |
| September 10, 2026 | 251.61M |
| September 09, 2026 | 252.62M |
| September 08, 2026 | 255.64M |
| September 04, 2026 | 263.70M |
| September 03, 2026 | 271.75M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| DBV Technologies SA | 574.77M |
| Akari Therapeutics Plc | 4.334M |
| Bicycle Therapeutics Plc | -280.85M |
| EDAP TMS SA | 142.35M |
| argenx SE | 60.66B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -21.79M |
| Revenue (Quarterly) | 5.222M |
| Total Expenses (Quarterly) | 27.01M |
| EPS Diluted (Quarterly) | -0.2165 |
| Gross Profit Margin (Quarterly) | 15.62% |
| Profit Margin (Quarterly) | -417.3% |
| Earnings Yield | -48.89% |
| Normalized Earnings Yield | -45.01 |